GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (BSP:B1SX34) » Definitions » Cyclically Adjusted PB Ratio

Boston Scientific (BSP:B1SX34) Cyclically Adjusted PB Ratio : 8.03 (As of May. 29, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Boston Scientific Cyclically Adjusted PB Ratio?

As of today (2024-05-29), Boston Scientific's current share price is R$388.05. Boston Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was R$48.31. Boston Scientific's Cyclically Adjusted PB Ratio for today is 8.03.

The historical rank and industry rank for Boston Scientific's Cyclically Adjusted PB Ratio or its related term are showing as below:

BSP:B1SX34' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.15   Med: 5.04   Max: 7.91
Current: 7.87

During the past years, Boston Scientific's highest Cyclically Adjusted PB Ratio was 7.91. The lowest was 1.15. And the median was 5.04.

BSP:B1SX34's Cyclically Adjusted PB Ratio is ranked worse than
87.5% of 472 companies
in the Medical Devices & Instruments industry
Industry Median: 2.105 vs BSP:B1SX34: 7.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Boston Scientific's adjusted book value per share data for the three months ended in Mar. 2024 was R$67.498. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$48.31 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Boston Scientific Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Boston Scientific's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Cyclically Adjusted PB Ratio Chart

Boston Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.15 5.39 5.77 5.58 6.28

Boston Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.82 6.12 5.82 6.28 7.17

Competitive Comparison of Boston Scientific's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Boston Scientific's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Cyclically Adjusted PB Ratio falls into.



Boston Scientific Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Boston Scientific's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=388.05/48.31
=8.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Boston Scientific's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=67.498/131.7762*131.7762
=67.498

Current CPI (Mar. 2024) = 131.7762.

Boston Scientific Quarterly Data

Book Value per Share CPI Adj_Book
201406 11.054 100.560 14.485
201409 11.815 100.428 15.503
201412 12.851 99.070 17.094
201503 15.240 99.621 20.159
201506 15.255 100.684 19.966
201509 18.604 100.392 24.420
201512 18.213 99.792 24.050
201603 17.628 100.470 23.121
201606 15.672 101.688 20.309
201609 15.489 101.861 20.038
201612 16.579 101.863 21.448
201703 16.112 102.862 20.641
201706 17.397 103.349 22.182
201709 17.315 104.136 21.911
201712 16.819 104.011 21.309
201803 16.706 105.290 20.909
201806 21.141 106.317 26.204
201809 24.613 106.507 30.453
201812 24.471 105.998 30.422
201903 25.498 107.251 31.329
201906 26.112 108.070 31.840
201909 28.664 108.329 34.868
201912 40.833 108.420 49.629
202003 48.202 108.902 58.327
202006 56.691 108.767 68.684
202009 58.697 109.815 70.436
202012 55.663 109.897 66.745
202103 62.358 111.754 73.530
202106 56.385 114.631 64.818
202109 60.992 115.734 69.446
202112 65.942 117.630 73.873
202203 58.257 121.301 63.288
202206 60.901 125.017 64.194
202209 64.592 125.227 67.970
202212 64.313 125.222 67.679
202303 64.675 127.348 66.924
202306 60.481 128.729 61.913
202309 63.669 129.860 64.609
202312 64.455 129.419 65.629
202403 67.498 131.776 67.498

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Boston Scientific  (BSP:B1SX34) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Boston Scientific Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Boston Scientific's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Boston Scientific (BSP:B1SX34) Business Description

Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Boston Scientific (BSP:B1SX34) Headlines

No Headlines